Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??
" 16,000 shareholders,none of whom holds more than about 8% of the company (very interesting !)

.got it pretty well figured out."

I guess that means that S/L no longer hold 9.9%

Share
New Message
Please login to post a reply